Babcock & Wilcox Enterprises Receives Continued Listing Standard Notice from NYSE
Babcock & Wilcox (NYSE: BW) has received a notice from the New York Stock Exchange (NYSE) on April 4, 2025, indicating non-compliance with continued listing standards due to its average closing stock price falling below $1.00 over a consecutive 30 trading-day period.
The company has a six-month cure period to regain compliance with the minimum share price requirement. During this period, BW's stock will continue trading on the NYSE, subject to other listing requirements. Compliance can be restored if the stock achieves a closing price of at least $1.00 and maintains an average closing price of $1.00 over any 30 trading-day period ending on the last trading day of any calendar month during the cure period.
The notice does not impact BW's business operations, SEC reporting obligations, or trigger any debt obligation violations.
Babcock & Wilcox (NYSE: BW) ha ricevuto una comunicazione dalla Borsa di New York (NYSE) il 4 aprile 2025, che indica la non conformità agli standard di quotazione continuativa a causa del prezzo medio di chiusura delle azioni sceso al di sotto di $1,00 per un periodo di 30 giorni di trading consecutivi.
La società ha un periodo di sei mesi per rimediare e ripristinare la conformità con il requisito del prezzo minimo delle azioni. Durante questo periodo, le azioni di BW continueranno a essere scambiate sulla NYSE, soggette ad altri requisiti di quotazione. La conformità può essere ripristinata se il titolo raggiunge un prezzo di chiusura di almeno $1,00 e mantiene un prezzo medio di chiusura di $1,00 su qualsiasi periodo di 30 giorni di trading che termina nell'ultimo giorno di trading di qualsiasi mese del calendario durante il periodo di rimediare.
La comunicazione non influisce sulle operazioni commerciali di BW, sugli obblighi di reporting SEC o attiva violazioni di obbligazioni di debito.
Babcock & Wilcox (NYSE: BW) ha recibido un aviso de la Bolsa de Nueva York (NYSE) el 4 de abril de 2025, indicando el incumplimiento de los estándares de cotización continua debido a que su precio promedio de cierre de acciones ha caído por debajo de $1.00 durante un período consecutivo de 30 días de negociación.
La empresa tiene un período de seis meses para corregir esta situación y recuperar el cumplimiento con el requisito del precio mínimo de las acciones. Durante este período, las acciones de BW continuarán cotizando en la NYSE, sujetas a otros requisitos de cotización. El cumplimiento se puede restaurar si las acciones logran un precio de cierre de al menos $1.00 y mantienen un precio promedio de cierre de $1.00 durante cualquier período de 30 días de negociación que termine en el último día de negociación de cualquier mes calendario durante el período de corrección.
El aviso no afecta las operaciones comerciales de BW, sus obligaciones de reporte ante la SEC ni activa violaciones de obligaciones de deuda.
밥콕 & 윌콕스 (NYSE: BW)는 2025년 4월 4일 뉴욕 증권 거래소(NYSE)로부터 평균 종가가 연속 30 거래일 동안 $1.00 이하로 떨어져 지속적인 상장 기준을 준수하지 못했다는 통지를 받았습니다.
회사는 최소 주가 요건을 회복하기 위해 6개월의 구제 기간을 갖습니다. 이 기간 동안 BW의 주식은 다른 상장 요건에 따라 NYSE에서 계속 거래됩니다. 주식이 $1.00 이상의 종가를 달성하고 구제 기간 동안의 마지막 거래일이 포함된 30 거래일 동안 평균 종가가 $1.00을 유지하면 준수를 회복할 수 있습니다.
이 통지는 BW의 사업 운영, SEC 보고 의무에 영향을 미치지 않으며, 채무 의무 위반을 유발하지 않습니다.
Babcock & Wilcox (NYSE: BW) a reçu une notification de la Bourse de New York (NYSE) le 4 avril 2025, indiquant un non-respect des normes de cotation continue en raison de la baisse du prix moyen de clôture de ses actions en dessous de 1,00 $ pendant une période consécutive de 30 jours de négociation.
L'entreprise dispose d'une période de six mois pour remédier à cette situation et retrouver la conformité avec l'exigence de prix minimum des actions. Pendant cette période, les actions de BW continueront à être négociées sur le NYSE, sous réserve d'autres exigences de cotation. La conformité peut être rétablie si l'action atteint un prix de clôture d'au moins 1,00 $ et maintient un prix de clôture moyen de 1,00 $ sur toute période de 30 jours de négociation se terminant le dernier jour de négociation de tout mois calendaire pendant la période de remédiation.
La notification n'a pas d'impact sur les opérations commerciales de BW, ses obligations de reporting auprès de la SEC, ni ne déclenche de violations d'obligations d'endettement.
Babcock & Wilcox (NYSE: BW) hat am 4. April 2025 eine Mitteilung von der New York Stock Exchange (NYSE) erhalten, die auf die Nichteinhaltung der fortlaufenden Listungsstandards hinweist, da der durchschnittliche Schlusskurs der Aktie über einen aufeinanderfolgenden Zeitraum von 30 Handelstagen unter $1,00 gefallen ist.
Das Unternehmen hat einen sechsmonatigen Heilungszeitraum, um die Einhaltung der Mindestaktienpreisanforderung wiederherzustellen. Während dieses Zeitraums wird die BW-Aktie weiterhin an der NYSE gehandelt, vorbehaltlich anderer Listungsanforderungen. Die Einhaltung kann wiederhergestellt werden, wenn die Aktie einen Schlusskurs von mindestens $1,00 erreicht und über einen beliebigen Zeitraum von 30 Handelstagen, der am letzten Handelstag eines Kalendermonats während des Heilungszeitraums endet, einen durchschnittlichen Schlusskurs von $1,00 aufrechterhält.
Die Mitteilung hat keine Auswirkungen auf die Geschäftstätigkeit von BW, die SEC-Berichtspflichten oder löst keine Verletzungen von Schuldenverpflichtungen aus.
- Company maintains NYSE listing during six-month cure period
- No impact on business operations or debt obligations
- Stock price has fallen below NYSE minimum requirement of $1.00
- Risk of potential NYSE delisting if compliance is not achieved within six months
Notice Has No Immediate Impact on the Listing or Trading of Babcock & Wilcox Common Stock
In accordance with the NYSE listing standards, the Company has a period of six months following receipt of the NYSE Notice to regain compliance with the minimum share price requirement. As required by the NYSE, the Company plans to respond timely to the NYSE that it intends to regain compliance with the minimum share price requirement.
Under the NYSE listing standards, the Company’s common stock will continue to be listed and traded on the NYSE during the cure period, subject to the Company’s compliance with other continued listing requirements. The Company can regain compliance at any time during the cure period if on the last trading day of any calendar month during the cure period, its common stock has a closing share price of at least
The NYSE Notice does not affect the Company’s business operations or its reporting obligations with the
About B&W
Headquartered in
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical or current fact included in this release are forward-looking statements, including without limitation statements regarding the Company’s plans with respect to the NYSE Notice. You should not place undue reliance on these statements. Forward-looking statements include words such as “expect,” “intend,” “plan,” “likely,” “seek,” “believe,” “project,” “forecast,” “target,” “goal,” “potential,” “estimate,” “may,” “might,” “will,” “would,” “should,” “could,” “can,” “have,” “due,” “anticipate,” “assume,” “contemplate,” “continue” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operational performance or other events.
The forward-looking statements included herein are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or otherwise, except as required by law. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties, including, but not limited to: reactions from our customers, suppliers, vendors, employees and other third parties to the Company’s receipt of the NYSE Notice; the Company’s ability to regain compliance with the minimum share price requirement within the applicable cure period; the Company’s ability to comply with other NYSE listing standards and maintain the listing of its common stock on the NYSE; that our financial condition raises substantial doubt as to our ability to continue as a going concern and we have entered into a number of amendments and waivers to our Debt Facilities; our need of additional financing to continue as a going concern; and any negative reactions to the substantial doubt about our ability to continue as a going concern by our customers, suppliers, vendors, employees and other third parties; and the risks and uncertainties described under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, and any subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, or other filings we make with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20250410721216/en/
Investor Contact:
Investor Relations
Babcock & Wilcox Enterprises, Inc.
704.625.4944 | investors@babcock.com
Media Contact:
Ryan Cornell, Public Relations Lead
Babcock & Wilcox Enterprises, Inc.
330.860.1345 | rscornell@babcock.com
Source: Babcock & Wilcox Enterprises, Inc.
FAQ
What is the deadline for Babcock & Wilcox (BW) to regain NYSE listing compliance?
What are the requirements for BW to regain NYSE listing compliance?
Will BW stock continue trading on NYSE during the compliance period?
Does the NYSE notice affect BW's business operations or debt obligations?
